Takeda Pharma A/S
Records under this name other than patents Takeda Pharma A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Takeda Pharma A/S
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,158,651 | Fentanyl composition for nasal administration Formerly held Term ended Term ended Jun 19, 2025 · From the USPTO record | Term ended | Term ended Jun 19, 2025 | From the USPTO record |
| US 8,450,339 | Compositions for treatment of common cold Term ended Term ended Feb 4, 2024 · From the USPTO record | Term ended | Term ended Feb 4, 2024 | From the USPTO record |
| US 8,017,627 | Fentanyl composition for nasal administration Term ended Term ended Oct 12, 2023 · From the USPTO record | Term ended | Term ended Oct 12, 2023 | From the USPTO record |
| US 7,652,030 | Compositions for treatment of common cold Term ended Term ended Nov 30, 2022 · From the USPTO record | Term ended | Term ended Nov 30, 2022 | From the USPTO record |
| US 8,231,899 | Quick release pharmaceutical compositions of drug substances Term ended Term ended Jan 22, 2022 · From the USPTO record | Term ended | Term ended Jan 22, 2022 | From the USPTO record |
| US D548,954 | Case for medical devices Formerly held Term ended Term ended Aug 21, 2021 · From the USPTO record | Term ended | Term ended Aug 21, 2021 | From the USPTO record |
| US 8,653,107 | Fentanyl composition for nasal administration Term ended Ended no later than Jul 31, 2021 · From the USPTO record | Term ended | Ended no later than Jul 31, 2021 | From the USPTO record |
| US 6,713,089 | Quick release pharmaceutical compositions of drug substances Term ended Term ended Jul 10, 2021 · From the USPTO record | Term ended | Term ended Jul 10, 2021 | From the USPTO record |
| US 6,599,529 | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) Term ended Term ended Jul 17, 2020 · From the USPTO record | Term ended | Term ended Jul 17, 2020 | From the USPTO record |
| US 6,159,501 | Modified release multiple-units dosage composition for release of opioid compounds Term ended Term ended Jun 22, 2018 · From the USPTO record | Term ended | Term ended Jun 22, 2018 | From the USPTO record |